The Clinical Hematology Research Career Development Program at Washington University prepares trainees (Heme Scholars) to address complex problems in non-malignant blood diseases and transfusion medicine and alleviate the shortage of academic physician-scientists in these medically important disciplines. Scholars are clinical or research Fellows, clinical or research Instructors, or recently appointed Assistant Professors. One or two Scholars per year are selected for the program, which provides support for two or three years of career development. Scholars pursue a Clinical Curriculum that involves inpatient and outpatient care of patients with specific non-malignant hematologic disorders, and a Didactic Curriculum that teaches the skills necessary for independent and ethical clinical research. The Didactic Curriculum draws on the strengths of postdoctoral and degree granting programs in biostatistics, epidemiology, public health, and clinical research at Washington University. Each Scholar participates in an intensive Mentored Research Experience to generate publishable results and preliminary data for subsequent independent grant applications. The program focuses on three major areas: (1) hematopoietic stem cell and leukocyte disorders, including paroxysmal nocturnal hemoglobinuria, aplastic anemia, congenital anemias, myleodysplastic syndrome and myeloproliferative disorders, and cellular therapies using hematopoietic stem cells;(2) hemostatic and thrombotic disorders, including von Willebrand disease, thrombotic microangiopathy, and other congenital or acquired hemorrhagic or thrombotic syndromes;and (3) hemoglobinopathies and transfusion medicine, including sickle cell disease and clinical issues involving transfusion support or apheresis. These research projects encompass pediatric, adolescent and adult subjects with non-malignant hematologic disorders. The program is designed to recruit outstanding Scholars from diverse backgrounds, to individualize their training based on their needs and experience, to continuously monitor and improve the curriculum, and to track Scholar performance. By these means, the Heme Scholar program expects to increase our national capacity for multidisciplinary translational and clinical research in non-malignant hematology and transfusion medicine.

Public Health Relevance

Non-malignant blood diseases of many kinds remain major threats to public health. The Clinical Hematology Research Career Development Program at Washington University trains the next generation of physician- scientists to improve the diagnosis and treatment of non-malignant blood diseases and to improve transfusion therapy for adults and children affected by these diseases. !

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
2K12HL087107-06
Application #
8286632
Study Section
Special Emphasis Panel (ZHL1-CSR-J (F1))
Program Officer
Werner, Ellen
Project Start
2006-09-28
Project End
2017-05-31
Budget Start
2012-09-01
Budget End
2013-05-31
Support Year
6
Fiscal Year
2012
Total Cost
$390,546
Indirect Cost
$27,966
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Fields, Melanie E; Hoyt-Drazen, Catherine; Abel, Regina et al. (2016) A pilot study of parent education intervention improves early childhood development among toddlers with sickle cell disease. Pediatr Blood Cancer 63:2131-2138
Sanfilippo, K M; Wang, T F; Gage, B F et al. (2016) Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma. Thromb Res 143:86-90
Cimino, Patrick J; Bredemeyer, Andy; Abel, Haley J et al. (2015) A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel. Exp Mol Pathol 98:568-73
Shirai, Cara Lunn; Ley, James N; White, Brian S et al. (2015) Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo. Cancer Cell 27:631-43
Engle, E K; Fisher, D A C; Miller, C A et al. (2015) Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia. Leukemia 29:869-76
O'Brian, Katiuscia; Luo, Suhong; Ganti, Arun et al. (2015) Short- and Long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy. Leuk Lymphoma :1-7
Hagemann, Ian S; Devarakonda, Siddhartha; Lockwood, Christina M et al. (2015) Clinical next-generation sequencing in patients with non-small cell lung cancer. Cancer 121:631-9
Klco, Jeffery M; Miller, Christopher A; Griffith, Malachi et al. (2015) Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. JAMA 314:811-22
Carson, Kenneth R; Riedell, Peter; Lynch, Ryan et al. (2015) Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma. J Geriatr Oncol 6:211-8
Guilliams, Kristin P; Fields, Melanie E; Hulbert, Monica L (2015) Higher-than-expected prevalence of silent cerebral infarcts in children with hemoglobin SC disease. Blood 125:416-7

Showing the most recent 10 out of 32 publications